Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                For Patients

For Patients

                        Learn About Your Medicines


                        Clinical Trials: What Patients Need to Know
          Rare Diseases at FDA
          Guide to Submitting Comments to the FDA
          Learn About Drug and Device Approvals
          Learn About Expanded Access and Other Treatment Options
          Learn About FDA Patient Engagement Home
          For Patients
          Learn About Your MedicinesFor Patients Learn About Your Medicines
  
  	
    Share
    Post
    Linkedin

    Email
    PrintPatient Information
Patient Package Inserts, Medication Guides. and Instructions for Use
Patient Package Inserts (PPI), Medication Guides (MG), and Instructions for Use (IFU) are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients use the medicine safe and effectively and try to
Prescription Safety
avoid serious adverse events. Not all medicines have patient information and if you have questions about your medicines you should always talk with your Healthcare Provider or Pharmacist. A description of these types of patient labeling are provided below.
Patient Labeling:
Patient Package Inserts (PPI) - Patient labeling that is part of the FDA-approved prescription drug labeling. PPIs are developed by the manufacturer, approved by the FDA, and are required to be dispensed with specific products or classes of products (i.e., oral contraceptives and estrogen-containing products) (see, 21 CFR 310.501 and 21 CFR 310.515). Other PPIs are submitted to the FDA voluntarily by the manufacturer and approved by the FDA, but their distribution is not mandated.
  Instructions for Use (IFU) - Patient labeling that is developed by the manufacturer, approved by the FDA, and dispensed with specific products that have complicated dosing instructions to help the patient use the product properly.
  Medication Guides (MG)- are paper handouts that come with many prescription medicines. The guides address issues that are specific to particular drugs and drug classes, and they contain FDA-approved information that can help patients avoid serious adverse events.FDA requires that Medication Guides be issued (see, 21CFR 208) with certain prescribed drugs and biological products when the Agency determines that:
certain information is necessary to prevent serious adverse effects
  patient decision-making should be informed by information about a known serious side effect with a product, or
  patient adherence to directions for the use of a product are essential to its effectiveness.Medication Guides are developed by the manufacturer, approved by the FDA, and required to be given to consumers each time the medication is dispensed. To see a complete list of all FDA approved Medication Guides.
You can search the approved Medication Guide list, Drugs@FDA or dailymed for instructions on how to take your medicines safely. To find the currently approved patient information you will need to follow these instructions.

Drugs@FDA****
Drugs@FDA Webpage
You will need to access Drugs@fda.
  You will need the medicine name.
  Type in the name of the medicine in the search box and select submit.Choose from the list the type of information you are interested in. For example, "Label Information."
  There may be various different formulations of the medicine. You will need to click on the correct medicine for more information.
  The drug details page will come up and you will select either Patient Package Insert, Label, Medication Guide, or Instructions for Use.*-or*-
DailyMed
Daily Med Webpage
You will need to access DailyMed.
  The search allows you to search by any of the following:
    drug name,
      NDC code,
      manufacturer name,
      drug class or
      SET ID.
  The search can be accessed on any page of the site by choosing the "Search Tools" link on a desktop/laptop or tablet.
  The search functionality is also available on the home page and respresented by the magnifying glass icon.
  On a mobile device, the search tool is accessed by choosing the magnifying glass icon on the top right of the screen.Drug Trials Snapshot
The FDA has developed Drug Trials Snapshots to provide information to the public about who participated in the clinical trials for new FDA approved drugs. Drug Trials Snapshot is part of a pilot project to provide information about the sex, age, race and ethnicity of clinical participants for a small group of recently approved drugs. In addition to information about who participates in the trial, each Snapshot also includes information on how the study was designed, results of the efficacy and safety studies and, if known, differences in efficacy and side effects among sex, race and age (referred to as subgroups). For more information visit Drug Trials Snapshotwebpage.

                                                                                  Content current as of:
      01/08/2018For Patients

          
                        Learn About Your Medicines


                        Clinical Trials: What Patients Need to Know
          Rare Diseases at FDA
          Guide to Submitting Comments to the FDA
          Learn About Drug and Device Approvals
          Learn About Expanded Access and Other Treatment Options
          Learn About FDA Patient Engagement
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop